PUBLICATION

Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents

Authors
Yang, J., Zhang, P., Hu, Y., Liu, T., Sun, J., Wang, X.
ID
ZDB-PUB-190302-1
Date
2019
Source
Journal of enzyme inhibition and medicinal chemistry   34: 651-656 (Journal)
Registered Authors
Keywords
3-Arylcoumarin, Alzheimer’s disease, antioxidant activity, cholinesterase inhibitors, monoamine oxidase inhibitors
MeSH Terms
  • Acetylcholinesterase/metabolism*
  • Alzheimer Disease/drug therapy*
  • Alzheimer Disease/metabolism
  • Animals
  • Antioxidants/chemical synthesis
  • Antioxidants/chemistry
  • Antioxidants/pharmacology*
  • Cholinesterase Inhibitors/chemical synthesis
  • Cholinesterase Inhibitors/chemistry
  • Cholinesterase Inhibitors/pharmacology*
  • Coumarins/chemical synthesis
  • Coumarins/chemistry
  • Coumarins/pharmacology*
  • Dose-Response Relationship, Drug
  • Molecular Structure
  • Monoamine Oxidase/metabolism*
  • Monoamine Oxidase Inhibitors/chemical synthesis
  • Monoamine Oxidase Inhibitors/chemistry
  • Monoamine Oxidase Inhibitors/pharmacology*
  • Rats, Wistar
  • Structure-Activity Relationship
  • Zebrafish
PubMed
30746966 Full text @ J Enzyme Inhib Med Chem
Abstract
Alzheimer's disease, a neurodegenerative illness, has the extremely complex pathogenesis. Accumulating evidence indicates there is a close relationship between several enzymes and Alzheimer's disease. Various substituted 3-arylcoumarin derivatives were synthesised, and their in vitro activity, including cholinesterase inhibitory activity, monoamine oxidase inhibitory activity, and antioxidant activity were investigated. Most of the compounds exhibited high activity; therefore 3-arylcoumarin compounds have the potential as drug candidates for the treatment of Alzheimer's disease.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping